Drug intelligence / Profile preview

Prevebe Twin

Development stage: Unknown
Lead developer: LYS PHARMA
Administration: Oral

Overview

Prevebe Twin is a specialized dietary supplement developed by LYS PHARMA specifically for nutritional support during twin or multiple pregnancies. Recognizing that multiple gestations place significantly higher physiological and nutritional demands on the mother, the product provides an optimized blend of vitamins and minerals. Key components typically include elevated levels of folic acid to support neural tube development and iron to maintain healthy hemoglobin levels and prevent maternal anemia, alongside other essential micronutrients like Vitamin D and Vitamin B12. It is marketed as a health functional food in South Korea to support maternal health and fetal development in high-demand pregnancy scenarios.

Brand names: Prevebe Twin
Other names: 프리베베 트윈

Targets

FOLR1 (FRα)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Prevebe Twin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prevebe Twin.

Explore the full profile